Lv01
0 积分 2022-08-22 加入
Variable Response to ALK Inhibitors in NSCLC with a Novel MYT1L-ALK Fusion
2小时前
待确认
Selpercatinib Controls Central Nervous System Disease in Patients With NSCLC With RET Fusion
2小时前
已完结
Efficacy of Immune Checkpoint Inhibitors in SMARCA4-Mutant NSCLC
2小时前
已完结
Thymic Carcinoma With Malignant Effusion—a Rare Cytologic and Radiologic Mimicker of Metastatic NSCLC
2小时前
已完结
Alectinib in resected ALK-positive non-small-cell lung cancer
2小时前
已完结
The Evolving Genomic Landscape of Barrett’s Esophagus and Esophageal Adenocarcinoma
3年前
已完结
皖公网安备34019202002308
